首页> 外文期刊>Journal of Chromatography, Biomedical Applications >Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography
【24h】

Determination of acyclovir in maternal plasma, amniotic fluid, fetal and placental tissues by high-performance liquid chromatography

机译:高效液相色谱法测定母体血浆,羊水,胎儿和胎盘组织中的阿昔洛韦

获取原文
获取原文并翻译 | 示例
           

摘要

Acyclovir {9-[(2-hydroxyethoxy)-methyl]-guanosine, Zovirax, ACV} is a synthetic purine nucleoside analog active against herpes simplex virus types 1 (HSV-1), 2 (HSV-2), and varicella zoster virus. Acyclovir has frequently been used in HSV-2 seropositive mothers to prevent prenatal transmission of herpes virus to their unborn children. A fast and reproducible HPLC method for the determination of the highly polar acyclvoir in maternal rat plasma, amniotic fluid, placental tissue, and fetal tissue has been developed and validated. Plasma and amniotic fluid samples were prepared by protein precipitation using 2 M perchloric acid and syringe filtering. Tissue samples were homogenized in distilled water, centrifuged, and extracted using a C_(18) solid-phase extraction method prior to analysis. Baseline resolution was achieved for acyclovir and the internal standard gancyclovir, an anti-viral of similar structure to acyclovir, using an Agilent Eclipse XDB C_8 column (150 * 2.1 mm, 5 μm). The mobile phase used for the plasma and amniotic fluid was 10 mM acetate/citrate buffer-3.7 mM aqueous octanesulfonic acid (87.5:12.5, v/v) at a flow-rate of 0.2 m./min. The mobile phase used for the tissue samples was 30 mM acetate/citrate buffer with 5 mM octanesulfonic acid-acetonitrile (99:1, v/v). Both aqueous mobile phase portions were pH adjusted to 3.08. All separations were done using an Agilent 1100 Series HPLC system with UV detection of 254 nm. The assay was validated for each matrix over a range of 0.25 - 100 μg/ml over 3 days using five replicates of three spiked concentrations. The relative standard deviation and percent error for each validation data set was < 15% for middle and high quality control (QC) points and < 20% for all ow QC points. All calibration curves showed good linearity with an R~2 > 0.99. The extraction efficiency for recovery of acyclovir from all matrices was > 80%.
机译:阿昔洛韦{9-[((2-羟基乙氧基)-甲基]-鸟苷,Zovirax,ACV}是一种合成的嘌呤核苷类似物,对1型单纯疱疹病毒,2型HSV-2和水痘带状疱疹病毒有活性。阿昔洛韦经常被用于HSV-2血清反应阳性的母亲,以防止疱疹病毒的产前传播给未出生的孩子。已经开发并验证了一种快速,可重现的HPLC方法,用于测定母鼠血浆,羊水,胎盘组织和胎儿组织中的高极性阿奇伏伊。通过使用2 M高氯酸沉淀蛋白质并用注射器过滤制备血浆和羊水样品。在分析之前,将组织样品在蒸馏水中匀浆,离心,并使用C_(18)固相萃取法萃取。使用安捷伦Eclipse XDB C_8色谱柱(150 * 2.1 mm,5μm),可实现无环鸟苷和内标更昔洛韦(与阿昔洛韦具有相似结构的抗病毒剂)的基线分离度。用于血浆和羊水的流动相是流速为0.2 m./min的10 mM乙酸盐/柠檬酸盐缓冲液-3.7 mM辛磺酸水溶液(87.5:12.5,v / v)。用于组织样品的流动相是30 mM乙酸盐/柠檬酸盐缓冲液和5 mM辛烷磺酸-乙腈(99:1,v / v)。将两个水性流动相部分的pH均调节至3.08。所有分离均使用Agilent 1100系列HPLC系统进行,紫外检测波长为254 nm。使用三个加标浓度的五次重复,在3天内对0.25-100μg/ ml范围内的每种基质进行了测定验证。每个验证数据集的相对标准偏差和百分比误差,对于中,高质量控制(QC)点,均<15%,对于所有低质量控制点,均<20%。所有校准曲线均显示出良好的线性,R〜2> 0.99。从所有基质中回收阿昔洛韦的提取效率均> 80%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号